LIMITATION OF THE DIAGNOSTIC SCREENING TOOL FOR NONALCOHOLIC STEATOHEPATITIS IN NON-OBESE JAPANESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE

被引：0
|
作者：
Nakamura, A. [1 ]
Yoneda, M. [2 ]
Sumida, Y. [3 ]
Miyoshi, H. [1 ]
Nakajima, A. [4 ]
Atsumi, T. [1 ]
Terauchi, Y. [4 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan
[2] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[3] Kyoto Prefectural Univ Med, Kyoto, Japan
[4] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70603-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO309
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [21] Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
    Yari, Zahra
    Fotros, Danial
    Hekmatdoost, Azita
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [22] Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients
    Shao, Congxiang
    Ye, Junzhao
    Li, Fuxi
    Lin, Yansong
    Wu, Tingfeng
    Wang, Wei
    Feng, Shiting
    Zhong, Bihui
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (06) : 1850 - 1860
  • [23] Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
    Li, Yifang
    Chen, Yanzhen
    Tian, Xing
    Zhang, Shanshan
    Jiao, Jian
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 2029 - 2039
  • [24] Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
    Yari, Zahra
    Fotros, Danial
    Hekmatdoost, Azita
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [25] The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis
    Sharma, Mithun
    Mitnala, Shasikala
    Vishnubhotla, Ravi K.
    Mukherjee, Rathin
    Reddy, Duvvur N.
    Rao, Padaki N.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 (02) : 147 - 158
  • [26] Clinical effectiveness of ezetimibe for a non-obese patient with nonalcoholic fatty liver disease
    Enjoji, Munechika
    Tanaka, Masatake
    Miyazaki, Masayuki
    Higuchi, Nobito
    Kato, Masaki
    Kotoh, Kazuhiro
    Matsunaga, Kazuhisa
    Nishinakagawa, Takuya
    Machida, Kazuyuki
    Nakashima, Manabu
    Nakamuta, Makoto
    AMERICAN JOURNAL OF CASE REPORTS, 2009, 10 : 148 - 151
  • [27] Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
    Kim, Tae Hyung
    Lee, Yoonseok
    Lee, Young-Sun
    Gim, Jeong-An
    Ko, Eunjung
    Yim, Sun Young
    Jung, Young Kul
    Kang, SeongHee
    Kim, Moon Young
    Kim, Hayeon
    Kim, Baek-hui
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yim, Hyung Joon
    Yeon, Jong Eun
    Um, Soon Ho
    Byun, Kwan Soo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
    Tae Hyung Kim
    Yoonseok Lee
    Young-Sun Lee
    Jeong-An Gim
    Eunjung Ko
    Sun Young Yim
    Young Kul Jung
    SeongHee Kang
    Moon Young Kim
    Hayeon Kim
    Baek-hui Kim
    Ji Hoon Kim
    Yeon Seok Seo
    Hyung Joon Yim
    Jong Eun Yeon
    Soon Ho Um
    Kwan Soo Byun
    Scientific Reports, 11
  • [29] Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems
    Tiniakos, Dina G.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (06) : 643 - 650
  • [30] Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshio Sumida
    Atsushi Nakajima
    Yoshito Itoh
    World Journal of Gastroenterology, 2014, 20 (02) : 475 - 485
12345